Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart MRI under the microscope: 2,349 patients reveal Real-World accuracy

NCT ID NCT03192891

Knowledge-focused Sponsor: Society for Cardiovascular Magnetic Resonance Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well a special heart MRI (called stress CMR) finds blocked arteries in real hospitals, not just research centers. Researchers tracked 2,349 people aged 35-85 who had symptoms of heart disease. They recorded heart attacks, deaths, and hospital visits to see if the MRI results could predict future problems. The goal was to gather evidence to help doctors decide when to use this test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2,349 people

The number who actually took part.

Started

Dec 2016

Finished

Nov 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Consecutive patients who underwent stress CMR perfusion imaging for evaluation of myocardial ischemia between 2008-2013.

Ages

35 to 85 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: all of the following at time of imaging: a) male or female at age 35-85 years, b) presence of either of the following sign/symptom that led to stress CMR imaging 1. Symptoms suspicious of ischemia, or 2. abnormal ECG with a suspicion of coronary artery disease c) Intermediate or high risk of significant coronary disease based on at least 2 of the following conditions: 1. patient age \> 50 for male, 60 for female 2. Diabetes: by either history or medical treatment 3. Hypertension: by either history or medical treatment 4. Hypercholesterolemia: by either history or medical treatment 5. family history of premature coronary disease: first degree relative at age \<= 55 male and \<=65 female 6. Body mass index \> 30 7. Any medical documentation of peripheral artery disease 8. Any history of myocardial infarction or percutaneous coronary intervention Exclusion Criteria: 1. Prior history of coronary artery bypass surgery (CABG) 2. Acute myocardial infarction within the past 30 days prior to CMR 3. any significant non-coronary cardiac conditions confirmed by medical documentation a. severe valvular heart disease, b. non-ischemic cardiomyopathy with left ventricular ejection fraction \<40%, c. infiltrative cardiomyopathy, d. hypertrophic cardiomyopathy, e. pericardial disease with significant constriction, or 4. active pregnancy, 5. any competing conditions leading to an expected survival of \< 2 years 6. Known inability to follow-up due to logistical reasons (e.g. patient lives in another country where follow-up is not feasible)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myocardial ischemia

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Houston Methodist

    Houston, Texas, 77030, United States

  • National Heart, Lung, and Blood Institute (NHLBI)

    Bethesda, Maryland, 20824, United States

  • New York-Presbyterian Brooklyn Methodist Hospital

    Brooklyn, New York, 11215, United States

  • Ohio State University

    Columbus, Ohio, 43210, United States

  • Revere Health

    Provo, Utah, 84604, United States

  • San Antonio Military Medical Center - Wilford Hall

    San Antonio, Texas, 78219, United States

  • Scripps Clinic

    La Jolla, California, 92037, United States

  • Sharon Regional Health System

    Hermitage, Pennsylvania, 16148, United States

  • University of Chicago

    Chicago, Illinois, 60637, United States

  • University of Illinois

    Chicago, Illinois, 60612, United States

  • University of Kentucky

    Lexington, Kentucky, 40536, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.